“We are thrilled to begin testing anywhere in the United States and worldwide with our first-of-their-kind mobile labs,” said Eric Canonico, CEO of MOTOPARA Foundation. “With the recent surge of COVID ...
LOS ANGELES--(BUSINESS WIRE)--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 ...
Thanks to Advances in Genomics, PCR Is Becoming More Common in Clinical Applications Since its invention by Kary B. Mullis in 1985, the polymerase chain reaction (PCR) has become well established, ...
CE-marked under the EU IVDR regulation, Diagnostics.AI's platform is the first to deliver AI algorithmic transparency and per-test auditability for clinical PCR diagnostics As the May 26th CE-IVDR ...
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years, digital PCR (dPCR) has captured the attention of researchers and clinicians ...
July 25 (UPI) --Scientists at Columbia University unveiled research Monday they said is "a step closer" toward bringing polymerase chain reaction, known as PCR, testing for COVID-19 and other viruses ...
ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc., a manufacturer of a highly advanced microfluidic molecular testing platform, announced the opening of Rheonix Laboratories LLC, a CLIA-certified clinical ...
CHICAGO – The principal lab for a nationwide coronavirus testing company under investigation by several states is now the focus of a federal agency probing allegations of misconduct at the site. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results